What Is Calculus of the Kidney: Symptoms & Treatment

A calculus of the kidney is the medical term for a kidney stone, a hard deposit of minerals and salts that forms inside the kidney. Most kidney stones are primarily made of calcium oxalate, and many grow on a foundation of calcium phosphate deposits called Randall’s plaques that sit on the inner surface of the kidney. Stone disease is remarkably common, with prevalence rates reaching nearly 15%, and roughly half of people who form one stone will form another within five years. The condition ranges from entirely painless to agonizing, and treatment depends almost entirely on where the stone is and how large it has grown.

How Kidney Stones Form

Stone formation begins at a microscopic level, long before any symptoms appear. Calcium deposits form in the tissue deep inside the kidney, specifically in the basement membranes of tiny structures called the loops of Henle. These initial deposits can be as small as 50 nanometers and are invisible without powerful microscopy. Surrounding cells show no damage or inflammation at this early stage, which is part of why the process goes unnoticed for so long.¹

Over time, these microscopic deposits spread outward through the tissue toward the surface lining of the renal papilla, the small bumps of tissue where urine drains from the kidney into the collecting system. When the surface lining breaks down, the underlying plaque becomes exposed to urine. Proteins and crystals from the urine then accumulate on the exposed plaque in alternating layers, until eventually the crystal growth escapes the body’s normal regulation and a calcium oxalate stone begins to build outward into the urine space.²

Not every stone follows this pathway. Some stones form from uric acid, others from struvite (associated with urinary infections), and a small percentage from cystine (linked to a rare inherited condition). But calcium-based stones account for the large majority of cases.³

When Stones Cause Symptoms and When They Stay Silent

Many kidney stones sit quietly inside the kidney without causing any trouble, sometimes for years. A stone that is not blocking urine flow and is not irritating surrounding tissue can be completely painless. In one study tracking asymptomatic stones over an average follow-up of about three and a half years, only about 28% eventually caused symptoms. A small but important fraction (around 3% of the asymptomatic stones) caused silent obstruction, blocking urine flow without producing pain, which was only caught on follow-up imaging.⁴

When a stone does move from the kidney into the ureter (the narrow tube connecting kidney to bladder), the result is often severe. The hallmark symptom is renal colic: intense, wave-like pain that typically starts in the flank and radiates toward the groin. The pain comes from the ureter contracting against the stone and from increased pressure behind the blockage, not from the stone cutting tissue. Other common symptoms include blood in the urine, nausea, vomiting, and a persistent urge to urinate. About 94% of people presenting with a symptomatic stone have detectable blood in their urine, but that means roughly 6% do not, so a clean urine test does not rule out a stone.⁵

Even stones that start out silent tend to grow over time. A long-term observation study found that about 77% of patients with untreated stones experienced some form of progression, with about a quarter eventually needing surgery. Stones larger than 4 mm at diagnosis and those in the lower pole of the kidney were more likely to grow, and higher uric acid levels in blood and urine predicted faster growth.⁶

Risk Factors You Can and Cannot Control

The single most modifiable risk factor is fluid intake. When you drink more, your kidneys produce more dilute urine, which means the minerals that form stones are less concentrated. A dose-response meta-analysis of observational studies found that each additional 500 mL of daily water intake was associated with a measurable reduction in stone risk.⁷ A systematic review spanning two decades of research confirmed the relationship between higher fluid intake, greater urine output, and fewer stones.⁸

Diet plays a more nuanced role than people realize. Foods high in oxalate can raise urinary oxalate levels, but the relationship is not as straightforward as “eat less oxalate, get fewer stones.” Only a handful of foods have been shown to significantly increase urinary oxalate excretion: spinach, rhubarb, beets, nuts, chocolate, tea, wheat bran, and strawberries. And counterintuitively, restricting dietary calcium actually makes stone risk worse, because calcium in the gut binds oxalate and prevents it from being absorbed into the bloodstream. Eating adequate calcium with meals reduces the amount of oxalate that reaches the kidneys.⁹

Obesity and certain surgeries also shift risk. Bariatric procedures, particularly those that reduce the gut’s ability to absorb nutrients, can increase stone formation. The risk is highest with purely malabsorptive procedures, moderate with gastric bypass, and lowest with restrictive procedures like sleeve gastrectomy.¹⁰

An underappreciated factor is the gut microbiome. A bacterium called Oxalobacter formigenes breaks down oxalate in the intestinal tract and is found in a large proportion of the healthy adult population. The hypothesis is that when this bacterium is absent, perhaps after antibiotic courses, more oxalate gets absorbed through the colon and eventually reaches the kidneys.¹¹ Early research into deliberately colonizing the gut with O. formigenes has shown some promise in reducing urinary oxalate levels, though this work is still in early stages.¹²

How Kidney Stones Are Diagnosed

If you show up to an emergency room with flank pain and suspected kidney stones, the imaging you receive matters more than you might think. A non-contrast CT scan is the gold standard: it can detect stones of virtually any composition and size, and it shows whether the stone is causing obstruction. Ultrasound is often used as a first-line tool, especially to avoid radiation exposure, and a large trial published in the New England Journal of Medicine found that starting with ultrasound versus CT led to similar outcomes in terms of return visits, hospitalizations, and diagnostic accuracy.¹³

That said, ultrasound has real limitations for stone surveillance. Its sensitivity for detecting stones runs around 77%, and it consistently overestimates stone size compared to CT, averaging about 8.7 mm versus 5.5 mm for the same stone. The overestimation is worse for smaller stones and in patients with higher body mass.¹⁴ Some studies have reported ultrasound sensitivity as low as 32–57% depending on the side of the body and the radiologist reading the images.¹⁵ The practical upshot: ultrasound is a reasonable starting point, but if your doctor suspects a stone that ultrasound does not show, a CT scan may be the next step.

For people with a history of stones, 24-hour urine collections can help predict recurrence. These tests measure levels of calcium, oxalate, uric acid, citrate, and other substances in urine over a full day. Research using joint modeling of repeated 24-hour urine collections has identified key predictors of stone recurrence, including urine pH, total volume, uric acid, calcium, and citrate levels.¹⁶

Managing the Pain

Kidney stone pain can be among the worst acute pain a person experiences. The first-line treatment for renal colic, based on systematic reviews of multiple randomized trials, is a non-steroidal anti-inflammatory drug (NSAID) such as ibuprofen, ketorolac, or diclofenac rather than an opioid. Patients treated with NSAIDs achieve greater reductions in pain scores, need less rescue medication, and experience significantly less vomiting compared to those receiving opioids.¹⁷ A more recent meta-analysis confirmed this pattern, finding a marginal benefit of NSAIDs over opioids in initial pain reduction, and substantially fewer side effects.¹⁸

This is worth knowing because many emergency rooms still default to opioids for severe pain. If you are in the ER with renal colic, asking specifically about IV ketorolac or another NSAID is reasonable. Opioids are not wrong, but they tend to cause more nausea and vomiting in a situation where you are probably already nauseated.

Medical Expulsive Therapy

For small to medium-sized stones lodged in the ureter, doctors sometimes prescribe a medication called tamsulosin (originally developed for prostate problems) to relax the smooth muscle in the ureter and help the stone pass on its own. The evidence here is genuinely mixed. A large meta-analysis of randomized controlled trials found that tamsulosin was associated with a 44% higher stone expulsion rate compared to placebo, shorter time to passage, and fewer episodes of pain.¹⁹

However, a well-designed randomized trial of nearly 500 patients found no significant difference: stone passage rates were 50% with tamsulosin versus 47% with placebo.²⁰ How do we reconcile these findings? The benefit of tamsulosin appears to be most consistent for larger ureteral stones (roughly 5–10 mm), where muscle relaxation makes a more meaningful difference. For very small stones that would pass regardless, the drug probably does not add much. A review of available data supports the use of alpha-blockers and acknowledges they can reduce pain episodes and hospital visits, even if the overall passage rate debate continues.²¹

Procedural Treatments for Stones That Will Not Pass

When a stone is too large to pass, is causing infection, or has not moved after a reasonable waiting period, procedural intervention is necessary. The three main options each have different strengths depending on the stone’s size, location, and density.

Shock wave lithotripsy (SWL, sometimes called ESWL) sends focused sound waves through the body to break a stone into fragments small enough to pass naturally. It is completely non-invasive, requires no incision, and is done as an outpatient. Success depends heavily on stone characteristics. Stones that are less dense on CT scan fare much better: stones below a certain density threshold had clearance rates above 90%, while very dense stones cleared only about half the time.²² Stone size also matters: stones under 10 mm respond far better than larger ones.²³ Gender, stone size, site, density, and the distance from the skin to the stone all significantly affect outcomes.²⁴

Ureteroscopy (URS) involves passing a thin, flexible scope up through the bladder and ureter to the stone, then breaking it with a laser. No external incision is needed. Compared to percutaneous nephrolithotomy (described below), flexible ureteroscopy for large kidney stones offers a shorter hospital stay, less blood loss, and faster recovery, with a higher clearance rate and fewer complications in one comparative study.²⁵ For stones in the 2–3 cm range, ureteroscopy and percutaneous approaches produced similar stone-free rates (76% versus 87%), but ureteroscopy patients had shorter hospital stays and shorter recovery, while needing more follow-up procedures.²⁶

Percutaneous nephrolithotomy (PCNL) involves making a small puncture through the back into the kidney and using instruments to break up and extract the stone directly. It has the highest single-session stone clearance rate, around 88% in one study versus about 71% for the retrograde ureteroscopic approach, but carries a higher risk of bleeding.²⁷ PCNL is generally reserved for very large stones (typically above 2 cm) or complex situations where other approaches are unlikely to succeed.

Preventing Recurrence

Given that recurrence rates reach 50% within five years, prevention is not optional for anyone who has had a stone. The foundation is hydration: aiming for enough fluid intake to produce at least 2.5 liters of urine per day substantially lowers the odds of forming another stone.⁷ Beyond water, certain medications can help depending on the stone type. Thiazide diuretics reduce calcium in the urine, citrate supplements raise urine citrate and pH (both of which inhibit stone crystal formation), and allopurinol can prevent calcium stones in people with high urinary uric acid.²⁸

Prophylactic treatment for asymptomatic stones, rather than just watching them, has some support. A retrospective study found that patients who received intervention for their silent stones had a significantly lower rate of stone-related events compared to those managed with observation alone. Stone size above 5 mm and elevated uric acid were significant factors predicting future problems.²⁹ The decision to treat or watch depends on the stone’s size, location, and the patient’s overall risk profile.

Kidney Stones During Pregnancy

Pregnant women face a particular set of challenges with kidney stones. The normal changes of pregnancy, including mild dilation of the ureters and shifts in calcium metabolism, can make stones both more common and harder to diagnose. CT scanning, the usual gold standard, is avoided because of radiation exposure to the fetus. Ultrasound is recommended as the first-line imaging tool, despite the accuracy limitations mentioned earlier.³⁰

Most small stones during pregnancy are managed conservatively with pain control, hydration, and watchful waiting. When intervention is necessary, ureteroscopy is considered safe and can clear the stone without leaving behind a stent that requires repeated exchanges. Complicated cases, such as an infected stone causing obstruction, require urgent drainage because the risk to both the mother and fetus from sepsis is high. A percutaneous nephrostomy tube or ureteral stent can provide emergency relief, though stents in pregnant patients tend to encrust faster and need more frequent replacement.³⁰

A Very Old Problem

Kidney stones are among the earliest documented surgical conditions. The ancient Roman physician Celsus provided the first recorded details of perineal lithotomy, a technique for removing bladder stones that persisted for centuries. Hippocrates famously warned physicians against “cutting for the stone,” leaving it instead to trained specialists. The field remained essentially surgical until the late twentieth century, when two breakthroughs changed everything: percutaneous stone access was established in 1976, and the first extracorporeal shock wave lithotripsy machine arrived in 1980. Within a generation, the treatment of stones went from open surgery requiring weeks of recovery to outpatient procedures and non-invasive sound waves.³¹ Modern flexible ureteroscopy, now a dominant technique, traces its origins to 1929, when it was first reported, but only became practical once laser lithotripsy technology caught up decades later. It is a field where the progression from crude intervention to minimally invasive precision happened within living memory.